Where to next in limited-stage small cell lung cancer? The role of immune checkpoint inhibitors
55:13
Precision targeting of MET in NSCLC: A multidisciplinary approach
31:53
Perspectives on EGFR-mutant and wildtype NSCLC: Tailoring treatment advances in late-stage disease
1:34
How do hearing aids for children work? | Boston Children's Hospital
51:31
Insights from EHA and ISTH 2024: How can we optimize care for patients with chronic ITP?
17:24
Updates in recurrent/metastatic nasopharyngeal carcinoma: The role of immune checkpoint inhibitors
58:02
Assessing the Use and Impact of Telemedicine in the Primary Care Setting for People with Dementia
40:57
Expanding HER2 horizons: Implications for NSCLC and beyond
51:13